GSA Capital Partners’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-35,647
| Closed | -$111K | – | 1994 |
|
|
2021
Q4 | $111K | Sell |
35,647
-249,449
| -87% | -$839K | 0.01% | 1306 |
|
|
2021
Q3 | $1.03M | Buy |
285,096
+138,599
| +95% | +$523K | 0.1% | 302 |
|
|
2021
Q2 | $524K | Buy |
146,497
+115,071
| +366% | +$406K | 0.06% | 594 |
|
|
2021
Q1 | $123K | Sell |
31,426
-14,527
| -32% | -$60K | 0.02% | 985 |
|
|
2020
Q4 | $193K | Sell |
45,953
-55,022
| -54% | -$212K | 0.03% | 1003 |
|
|
2020
Q3 | $377K | Buy |
+100,975
| New | +$430K | 0.06% | 586 |
|
|
2020
Q1 | – | Sell |
-16,840
| Closed | -$106K | – | 1801 |
|
|
2019
Q4 | $106K | Buy |
+16,840
| New | +$99K | 0.01% | 1335 |
|
|
2018
Q3 | – | Sell |
-250,967
| Closed | -$740K | – | 2095 |
|
|
2018
Q2 | $740K | Sell |
250,967
-209,600
| -46% | -$497K | 0.04% | 933 |
|
|
2018
Q1 | $1.04M | Buy |
460,567
+51,900
| +13% | +$121K | 0.05% | 632 |
|
|
2017
Q4 | $1.21M | Hold |
408,667
| – | – | 0.07% | 485 |
|
|
2017
Q3 | $1.21M | Sell |
408,667
-80,100
| -16% | -$244K | 0.08% | 397 |
|
|
2017
Q2 | $1.37M | Buy |
488,767
+44,700
| +10% | +$94.3K | 0.09% | 332 |
|
|
2017
Q1 | $844K | Buy |
444,067
+362,973
| +448% | +$700K | 0.05% | 754 |
|
|
2016
Q4 | $142K | Buy |
+81,094
| New | +$166K | 0.01% | 1653 |
|
|
2015
Q2 | – | Sell |
-42,822
| Closed | -$450K | – | 2422 |
|
|
2015
Q1 | $450K | Buy |
42,822
+8,068
| +23% | +$110K | 0.02% | 1464 |
|
|
2014
Q4 | $418K | Buy |
+34,754
| New | +$528K | 0.03% | 1060 |
|
Other funds holding BDSI
GSA Capital Partners's BDSI Position: Q1 2022 in Review
GSA Capital Partners sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 35,647 shares — an estimated $111K sold.
GSA Capital Partners first reported a position in BDSI in Q4 2014 and held it in 16 quarters. The position peaked at $1.37M in Q2 2017. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- GSA Capital Partners reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- GSA Capital Partners sold 35,647 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $111K.
- GSA Capital Partners first reported a position in BioDelivery Sciences International, Inc. in Q4 2014 and held it in 16 quarters.
- GSA Capital Partners's BioDelivery Sciences International, Inc. position peaked at $1.37M in Q2 2017.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on GSA Capital Partners's 13F filing for Q1 2022, filed 11 May 2022.